The Latest Research in Clinical Neuroradiology

A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Nuclear Medicine & Radiology".

Deadline for manuscript submissions: 15 September 2024 | Viewed by 783

Special Issue Editor


E-Mail Website
Guest Editor
Neuroradiology Unit, Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, University of Brescia and ASST Spedali Civili Hospital, Brescia, Italy
Interests: neuroimaging; machine learning; fMRI; eye tracking; movement; cognitive functions
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

What do we expect to happen in the next few years in the field of diagnostic and interventional neuroradiology, but also in neuroscience research? New developments have been made in the field of neuroradiology and have established powerful methods for saving patients’ lives and improving their quality of life. A broad range of computer-aided methods for analyzing and quantifying brain structure and function has been put on the market. These methods promise to increase the sensitivity for detecting brain abnormalities, which may be invisible to the human eye. In the field of interventional stroke treatment, big steps forward have been made, and preoperative task-based fMRI is a more and more practical and more and more highly sensitive tool for localizing eloquent cortical areas in patients affected by brain tumors. Furthermore, MRI has led to improvements in the accuracy of multiple sclerosis diagnosis and a deeper understanding of disease progression. Neuroimaging helps physicians diagnose mental illnesses and find novel treatments for them. Neuroradiology is increasingly striving towards solutions that can improve the quality of understanding, diagnosis, and treatment; in this Special Issue, we welcome authors to submit papers on the latest developments in clinical neuroradiology.

Dr. Daniele Corbo
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • fMRI
  • neuroimaging
  • stroke
  • tumor
  • multiple sclerosis
  • amyotrophic lateral sclerosis
  • neurodegeneration
  • autism spectrum disorder (ASD)
  • psychiatric disorders

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

19 pages, 13602 KiB  
Article
Magnetic Resonance Imaging of Central Nervous System Manifestations of Type 1 Neurofibromatosis: Pictorial Review and Retrospective Study of Their Frequency in a Cohort of Patients
by Stefano Di Pietro, Linda Reali, Emanuela Tona, Giuseppe Belfiore, Andrea Domenico Praticò, Martino Ruggieri, Emanuele David, Pietro Valerio Foti, Orazio Giuseppe Santonocito, Antonio Basile and Stefano Palmucci
J. Clin. Med. 2024, 13(11), 3311; https://doi.org/10.3390/jcm13113311 - 4 Jun 2024
Viewed by 410
Abstract
Background: type 1 neurofibromatosis (NF1) is the most common neurocutaneous disorder, and it is an inherited condition that causes a tumour predisposition. Central nervous system (CNS) manifestations are a significant cause of morbidity and mortality in NF1. We provide a pictorial review [...] Read more.
Background: type 1 neurofibromatosis (NF1) is the most common neurocutaneous disorder, and it is an inherited condition that causes a tumour predisposition. Central nervous system (CNS) manifestations are a significant cause of morbidity and mortality in NF1. We provide a pictorial review of neuroradiological features of NF1, with emphasis on magnetic resonance imaging (MRI), and we assess the frequency of those features on a cohort of NF1 patients. Methods: we retrospectively evaluated all patients with a diagnosis of NF1 who underwent MRI of the spine and brain in our centre over a period of almost 5 years. A total of 74 patients were enrolled, 28 males and 46 females, with a mean age of 21 ± 12.67 years. The frequency of CNS manifestations encountered in our cohort of NF1 patients was assessed and compared with the data found in other studies published in the literature. Results: many of our findings were in line with the literature, and possible interpretations for those that turned out to be different were suggested in the discussion. Conclusion: imaging plays a central role in the diagnosis and management of NF1, and the knowledge of CNS manifestations could be critical for its early detection and identification, such as for treatment planning and prognostic implications. Full article
(This article belongs to the Special Issue The Latest Research in Clinical Neuroradiology)
Show Figures

Figure 1

Back to TopTop